Solriamfetol Improved Sleepiness in Early Shift Work
TL;DR: A 2026 study in NEJM Evidence found that solriamfetol added 9.4 minutes of objective wakefulness in early-morning shift work disorder after 4 weeks, without a higher overall adverse-event rate than placebo. Key Findings 78 early-morning workers: Participants had excessive sleepiness linked to shifts starting between 3 a.m. and 7 a.m. Randomized double-blind design: The …
